Function and assembly of the Ebola virus nucleocapsid

Information

  • Research Project
  • 10065819
  • ApplicationId
    10065819
  • Core Project Number
    R01AI118016
  • Full Project Number
    7R01AI118016-05
  • Serial Number
    118016
  • FOA Number
    PA-13-302
  • Sub Project Id
  • Project Start Date
    3/1/2016 - 8 years ago
  • Project End Date
    2/29/2020 - 4 years ago
  • Program Officer Name
    REPIK, PATRICIA M
  • Budget Start Date
    7/1/2019 - 5 years ago
  • Budget End Date
    2/29/2020 - 4 years ago
  • Fiscal Year
    2019
  • Support Year
    05
  • Suffix
  • Award Notice Date
    12/11/2019 - 5 years ago

Function and assembly of the Ebola virus nucleocapsid

? DESCRIPTION (provided by applicant): Ebola virus is among the deadliest viruses known and has caused on ongoing and sustained epidemic in Western Africa 2013-2015. The mysteries behind Ebola virus RNA transcription, replication and viral assembly remain mysteries in part, because no high- resolution structural models yet exist by which we may interpret these processes. The mission of this project is to define the structural and biochemical mechanisms governing Ebola virus RNA synthesis and viral assembly. The viral nucleocapsid is a multi-protein-RNA complex at the core of each virion that serves as a molecular machine to synthesize and encapsidate new copies of the viral RNA genome. The viral proteins in this machine have both positive and negative influences on viral RNA synthesis and control the balance of transcription and replication. Understanding the structures, protein-protein interactions, and assemblies of this nucleocapsid machine is key to development of antivirals. However, current low resolution models of the nucleocapsid present conflicting models. Here, we propose complementary crystallographic analysis of each complex that builds the nucleocapsid (NP-RNA, NP-VP35, NP-VP24, NP-VP30 and NP-VP40), combined with high-resolution electron microscopy reconstructions of assembled nucleocapsids. The EM reconstructions will be achieved using state-of-the-art instrumentation, innovative techniques, and high-quality purified samples, and the structural findings will be supported by biochemical, biophysical and functional analysis. Importantly, crystals are in hand for nearly all proposed complexes and functional assays are operational in the laboratory. The resulting structures of the viral nucleocapsid and its component assemblies will transform our understanding of the assembly and replication of Ebola and emerging filoviruses. Further, the results of this proposal will provide roadmaps for functional analysis of these viruses as well as strategies for development of antivirals to defend human populations against them.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R01
  • Administering IC
    AI
  • Application Type
    7
  • Direct Cost Amount
    124031
  • Indirect Cost Amount
    102946
  • Total Cost
    226977
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:226977\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    LA JOLLA INST FOR ALLERGY & IMMUNOLGY
  • Organization Department
  • Organization DUNS
    603880287
  • Organization City
    LA JOLLA
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    920371387
  • Organization District
    UNITED STATES